Th1 and Th2 deviation of myelin-autoreactive T cells by altered peptide ligands is associated with reciprocal regulation of Lck, Fyn, and ZAP-70

Journal of Immunology

Volumn 163, Issue 12, 1999, Pages 6393-6402

  Singh, Rana A K ^a,c   Zang, Ying C Q ^a,c   Shrivastava, Anju ^b   Hong, Jian ^a,c   Wang, George T ^c   Li, Sufang ^a,c   Tejada Simon, Maria V ^a   Kozovska, Milena ^a   Rivera, Victor M ^a   Zhang, Jingwu Z ^a,b,c  

^a Multiple Sclerosis Res Laboratory   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; HISTIDINE; LIGAND; MYELIN BASIC PROTEIN; PEPTIDE; PROTEIN KINASE FYN; PROTEIN KINASE LCK; PROTEIN KINASE ZAP 70; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SUBSTITUTION; ARTICLE; AUTOIMMUNE DISEASE; CELL CLONE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ALANINE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CLONE CELLS; ENZYME ACTIVATION; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FYN; TH1 CELLS; TH2 CELLS; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 0032734639     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Wange, R. L., and L. E. Samelson. 1996. Complex complexes: signaling at the TCR. Immunity 5:197.
2. Chan, A. C., D. M. Desai, and A. Weiss. 1994. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu. Rev. Immunol. 12:555.
3. Perlmutter, R. M., S. D. Levin, M. W. Appleby, S. J. Anderson, and J. Alberola-Ila. 1993. Regulation of lymphocyte function by protein phosphorylation. Annu. Rev. Immunol. 11:451.
4. lck. Nature 338:257.
5. lck with CD4 in antigen-specific signal transduction in T cells. Cell 64:511.
6. lck interacts via its src homology 2 domain with the ZAP-70 kinase J. Exp. Med. 179:1163.
7. lck/CD4 to the activated T cell receptor/CD3/ζ complex. J. Exp. Med. 181:1997.
8. Sette, A., J. Alexander, J. Ruppert, K. Snoke, A. Franco, G. Ishioka, and H. M. Grey. 1994. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 12:413.
9. Jameson, S. C., and M. J. Bevan. 1995. T cell receptor antagonists and partial agonists. Immunity 1:1.
10. Evavold, B. D., and P. M. Allen. 1991. Separation of 1L-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252:1308.
11. Evavold, B. D., J. Sloan-Lancaster, and P. M. Allen. 1993. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol. Today 12:602.
12. Windhagen, A., C. Scholz, P. Hollsberg, H. Fukaura, A. Sette, and D. A. Hafler. 1995. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 4:373.
13. Nicholson, L. B., J. M. Greer, R. A. Sobel, M. B. Lees, and V. K. Kuchroo. 1995. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 4:397.
14. + T cells. J. Immunol. 157:2160.
15. Kuchroo, V. K., R. A. Sobel, J. C. Laning, C. A. Martin, E. Greenfield, M. E. Dorf, and M. B. Lees. 1992. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein: fine specificity and T cell receptor Vβ usage. J. Immunol. 148:3776.
16. Miller, S. D., and W. J. Karpus. 1994. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol. Today 8:356.
17. Khoury, S. J., W. W. Hancock, and H. L. Weiner. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down-regulation of inflammatory cytokines and differential up-regulation of transforming growth factor β, interleukin 4. and prostaglandin E expression in the brain. J. Exp. Med. 176:1355.
18. Merrill, J. E., D. H. Kono, J. Clayton, D. G. Ando, D. R. Hinton, and F. M. Hofman. 1992. Inflammatory leukocytes and cytokines in the peptideinduced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. USA 89:574.
19. Chen, Y., V. K. Kuchroo, J. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237.
20. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
21. Ota, K., M. Matsui, E. L. Milford, G. A. Mackin, H. L. Weiner, and D. A. Hafler. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183.
22. Zhang, J. 1995. Multiple sclerosis: perspectives on autoimmune pathology and prospects for therapy. In Current Neurology, Vol. 15. S. H. Appel, ed. Mosby-Year Book, St. Louis, p. 115.
23. Hermans, G., P. Stinissen, L. Hauben, E. Van den Berg-Loonen, J. Raus, and J. Zhang. 1997. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals. Ann. Neurol. 42:18.
24. Kozovska, M., Y. C. Zang, I. Aebischer, S. Lnu, V. M. Rivera, P. D. Crowe, S. A. Boehme, and J. Z. Zhang. 1998. T cell recognition motifs of an immunodominant peptide of myelin basic protein in patients with multiple sclerosis: structural requirements and clinical implications. Eur. J. Immunol. 6:1894.
25. Zhang, J., R. Medaer, P. Stinissen, D. Hafler, and J. Raus. 1993. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 261:1451.
26. Zhang, J., S. Markovic-Plese, B. Lacet, J. Raus, H. L. Weiner, and D. A. Hafler. 1994. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:973.
27. Vandevyver, C., N. Mertens, P. van den Elsen, R. Medaer, J. Raus, and J. Zhang. 1995. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur. J. Immunol. 4:958.
28. Zang, Y. C., M. Kozovska, I. Aebischer, S. Li, S. Boehme, P. Crowe, V. M. Rivera, and J. Zhang. 1998. Restricted TCR Vα gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis. Int. Immunol. 7:991.
29. Sanger, F., and A. R. Coulson. 1975. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J. Mol. Biol. 94:441.
30. Wucherpfennig, K. W., A. Sette, S. Southwood, C. Oseroff, M. Matsui, J. L. Strominger, and D. A. Hafler. 1994. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J. Exp. Med. 179:279.
31. Hemmer, B., B. T. Fleckenstein, M. Vergelli, G. Jung, H. McFarland, R. Martin, and K. H. Wiesmuller. 1997. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J. Exp. Med. 185:1651.
32. Dianzani, U., A. Shaw, B. K. al-Ramadi, R. T. Kubo, and C. A. Janeway Jr. 1992. Physical association of CD4 with the T cell receptor. J. Immunol. 148:678.
33. Racioppi, L., G. Matarese, U. D'Oro, M. De Pascale, A. M. Masci, S. Fontana, and S. Zappacosta. 1996. The role of CD4-Lck in T-cell receptor antagonism: evidence for negative signaling. Proc. Natl. Acad. Sci. USA 93:10360.
34. fyn and ZAP-70 with T-cell receptor activation motifs: defining the nature of a signaling motif. Mol. Cell. Biol. 14:3729.
35. fyn. Cell 70:751.
36. fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell 70:741.
37. Martin, R., P. Calabresi, and H. F. McFarland. 1998. Experimental immunotherapies of multiple sclerosis. In Immunotherapy in Neuroimmunologic Diseases. Zhang et al., eds. Martin Dunitz, London, p. 29.
38. + cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J. Immunol. 148:1359.
39. Zhang, J., R. Medaer, G. Hashim, C. Ying, E. van den Berg-Loonen, and J. Raus. 1992. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity. Ann. Neurol. 32:330.
40. Valli, A., A. Sette, L. Kappos, C. Oseroff, J. Sidney, G. Miescher, M. Hochberger, E. D. Albert, and L. Adorini. 1993. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cell from multiple sclerosis patients. J. Clin. Invest. 91:616.
41. Wucherpfennig, K. W., J. Zhang, C. Witek, M. Matsui, Y. Modabber, K. Ota, and D. A. Hafler. 1994. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J. Immunol. 152:5581.
42. Hong, J., Y. Zang, M. V. Tejada-Simon, S. Li, R. Singh, D. Yang, V. M. Rivera, J. M. Killian, and J. Zhang. 1999. A common T cell receptor V-D-J sequence in Vβ13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis. J. Immunol. 163:3530.
43. Sloan-Lancaster, J., and P. M. Allen. 1996. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1.
44. Lovett-Racke, A. E., J. L. Trotter, J. Lauber, P. J. Perrin, C. H. June, and M. K. Racke. 1998. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients: a marker of activated/memory T cells. J. Clin. Invest. 101:725.
45. Scholz, C., K. T. Patton, D. E. Anderson, G. J. Freeman, and D. A. Hafler. 1998. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J. Immunol. 160:1532.
46. Janeway, C. A. Jr., U. Dianzani, P. Portoles, S. Rath, E. P. Reich, J. Rojo, J. Yagi, and D. B. Murphy. 1989. Cross-linking and conformational change in T-cell receptors: role in activation and in repertoire selection. Cold Spring Harbor Symp. Quant. Biol. 54:657.
47. Straus, D. B., and A. Weiss. 1992. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70:585.
48. fyn (T) activity: detection of associated proteins at 72 and 120-130 kD. Mol. Immunol. 29:1417.
49. Sloan-Lancaster, J., A. S. Shaw, J. B. Rothbard, and P. M. Allen. 1994. Partial T cell signaling: altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy. Cell 79:913.
50. Tamura, T., H. Nakano, H. Nagase, T. Morokata, O. Igarashi, Y. Oshimi, S. Miyazaki, and H. Nariuchi. 1995. Early activation signal transduction pathways of Th1 and Th2 cell clones stimulated with anti-CD3: roles of protein tyrosine kinases in the signal for IL-2 and IL-4 production. J. Immunol. 155:4692.
51. Al-Ramadi, B. K., T. Nakamura, D. Leitenberg, and A. L. Bothwell. 1996. Deficient expression of p56(lck) in Th2 cells leads to partial TCR signaling and a dysregulation in lymphokine mRNA levels. J. Immunol. 157:4751.